https://clinicaltrials.gov/ct2/show/NCT02764489?type=Intr&cond=hemophilia&lupd_s=02%2F27%2F2019&lupd_d=14
Condition : Hemophilia A or B With Inhibitors
Intervention : Biological: FEIBA
Sponsors : Baxalta now part of Shire; Baxalta Innovations GmbH, now part of Shire
Recruiting
FEIBA Reconstitution Volume Reduction and Faster Infusion Study (FEIBA STAR)
NCT02764489
Fri, 06 May 2016 12:00:00 EDT
Last Update Posted: 03/13/19 10:19AM
